Skip to content

Clinical trials

Phase 1 Ovarian Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 1 Country / region: Netherlands Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20091
20101
20113
20121
20133
20152
20162
20172
20192
20201
20211
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated3
Active, not recruiting2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Medical Center Groningen4
AbbVie2
AstraZeneca2
Novartis Pharmaceuticals2
Radboud University Medical Center2
The Netherlands Cancer Institute2
Array Biopharma, now a wholly owned subsidiary of Pfizer1
BioNTech Cell & Gene Therapies GmbH1
Celgene1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms22
Breast Neoplasms8
Endometrial Neoplasms6
Stomach Neoplasms5
Carcinoma, Non-Small-Cell Lung3
Colonic Neoplasms3
Colorectal Neoplasms3
Carcinoma, Transitional Cell2
Esophageal Neoplasms2
Fallopian Tube Neoplasms2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.